-
02-12-2014, 08:15 PM
#10691
-
02-12-2014, 08:26 PM
#10692
Member
-
02-12-2014, 08:38 PM
#10693
Originally Posted by klid
Probably >1% chance
Greater than 1% eh?
Sounds like a bet worthy of the good ol' Winnie Blues then!
-
02-12-2014, 08:43 PM
#10694
Originally Posted by black knat
That is not quite right. The report is a review of all existing published literature on "Emerging Approaches to Diagnosis and Treatment of Non-Muscle-Invasive Bladder Cancer" - this includes the Journal of Urology paper on CXBladder. The report is in that sense not new science. The report assess the strength of evidence ("SOE") in favour of Cxbladder (ie the Journal of Urology paper) as "weak".
I really dont see how this is considered irrelevant. In terms of everyone being hyped up on the tests (and sorry Miner-that 2nd page disclaimer is not convincing)
How is that going to translate into a glowing CMS announcement?- Bad news with a 2nd page disclaimer(sort of) is not good news in my book
-just looking for a bit of clarity on the subject
Last edited by skid; 02-12-2014 at 08:47 PM.
-
02-12-2014, 08:48 PM
#10695
And this, ..... ..... who's there ?
Attachment 6553
-
02-12-2014, 09:21 PM
#10696
Quite a few indulged in the mass debate today......
Hey Clint, do we have a policy on backing up invoices?
-
02-12-2014, 09:25 PM
#10697
Member
Originally Posted by Minerbarejet
Bet you cant resist and sneak a peek. Lol. I tried it.
Haha, you are probably right Miner, it's human nature after all....
-
02-12-2014, 09:50 PM
#10698
Originally Posted by Harvey Specter
I think you guys are forgetting your double entry accounting.
If you accrue something in Accounts receivable, what is the other side of the entry?? It has to be revenue - Debit accounts receivable, credit Revenue.
Then when the cash is received, the entry is Debit Bank, Credit accounts receivable.
For them to be accuring, there needs to be virtual certainty for the audit to sign off on it (of the contract and the price).
I've had a quick look and cant find any reference to accruing for CMS sales. If you can point me to the right page, I can take a look.
Scientists do accounting differently harvey.
We all know profit is not part of their lingo, or thinking, so they do things their way.
Have a lady on board now who supposedly knows about accounting so in future things might make more sense
-
02-12-2014, 10:58 PM
#10699
Member
To get your foot in the door ANYWHERE, you gotta give heaps away for trials. Applies across the board: online accounting software, new building materials, pharmaceuticals, acne snake oil on tv. Free 30 day trial! just pay the postage! Aint nobody gonna buy your widgets if they cant try them. Keep on with the freebies to the industry, try the milk, try the milk, I got shares in the cow.
-
02-12-2014, 11:06 PM
#10700
Originally Posted by cammo
To get your foot in the door ANYWHERE, you gotta give heaps away for trials. Applies across the board: online accounting software, new building materials, pharmaceuticals, acne snake oil on tv. Free 30 day trial! just pay the postage! Aint nobody gonna buy your widgets if they cant try them. Keep on with the freebies to the industry, try the milk, try the milk, I got shares in the cow.
I also have wondered about what inducement hurdles they might be facing. I'd guess big-pharma would have plenty of incentive schemes. You would hope best practice would usurp shiny things, but I wouldn't count on it
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks